NIH-funded research R01 grant

Using automated machine learning to understand how HIV interacts with addictive drugs

Official title: Knowledge-guided automated machine learning methods for modeling the interaction of HIV with addictive drugs

Funded at Cedars-Sinai Medical Center · NIH-11127698 · Data updated 2026-11-12

This study is working on new tools to help researchers understand how substance abuse and HIV affect health outcomes, making it easier for everyone to analyze important data and improve care for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$491,450
NIH project number5R01LM014572-02
Project IDNIH-11127698 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who also have a history of substance abuse.

Less likely to help

Patients who do not have HIV or substance abuse issues may not benefit from this research.

What this research studies

This research aims to develop advanced data mining and analytics methods to help the substance abuse and HIV research communities better predict disease outcomes. By utilizing automated machine learning (AutoML), the project seeks to make complex data analysis accessible to all researchers, regardless of their technical expertise. The goal is to analyze multimodal data, including biomarkers related to substance abuse and HIV, to improve clinical decision-making and patient care. The research will leverage an open-source platform called Tree-Based Pipeline Optimization (TPOT) to streamline the process of selecting and optimizing machine learning algorithms for clinical data.

Why it matters

Potential benefit: If successful, this research could lead to improved prediction of HIV progression and better treatment strategies for patients with substance abuse issues.

How similar studies have gone: Other research has shown success in using machine learning approaches to analyze complex biomedical data, indicating that this method has potential for impactful results.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Moore, Jason H. — Cedars-Sinai Medical Center
  • Study coordinator: Moore, Jason H.

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.